Putting the award page together from the records…
Putting the award page together from the records…
University of Pittsburgh - of the Commonwealth System of Higher Education received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $37.61M obligated so far for health r&d services; health care - other; applied research. It runs to 2030-05-31, or to 2033-09-29 if every option is exercised.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75A50123C00047, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75A50123C00047_7505_-NONE-_-NONE-
University of Pittsburgh - of the Commonwealth System of Higher Education: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys
PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
85 subawards totaling $22.48M (59.8% of what was obligated), as University of Pittsburgh - of the Commonwealth System of Higher Education reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
The 25 largest of 27; the rest are on USAspending.gov.
| Date | To | Amount | For |
|---|---|---|---|
| 2024-05-06 | The Regents of the University of Colorado | $1.89M | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-05-06 | The Regents of the University of Colorado | $1.89M | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-05-06 | The Regents of the University of Colorado | $1.89M | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2026-09-14 | University of Rochester | $718.3K | THIS SUBAWARD IS TO SUPPORT THE MATIC-2 CLINICAL TRIAL, WHICH EXAMINES THE EFFECTIVENESS, SAFETY AND MECHANISMS BETWEEN MULTIPLE RESUSCITATION PRACTICES IN CHILDREN WITH LIFE THREATENING BLEEDING FROM TRAUMATIC INJURY. |
| 2025-02-27 | University of Alabama at Birmingham | $374.8K | FUNDS HAVE BEEN BUDGETED FOR UNIVERSITY OF ALABAMA AT BIRMINGHAM TO PLAN, ORGANIZE AND IMPLEMENT THE PROTECTIONS ASSOCIATED WITH FEDERAL REGULATIONS 21 CFR 50.24, EXCEPTION FROM INFORMED CONSENT (EFIC) REQUIREMENTS FOR… |
| 2026-09-08 | The University of Texas Health Science Center at San Antonio | $346.2K | THIS SUBAWARD IS TO SUPPORT THE MATIC-2 CLINICAL TRIAL, WHICH EXAMINES THE EFFECTIVENESS, SAFETY AND MECHANISMS BETWEEN MULTIPLE RESUSCITATION PRACTICES IN CHILDREN WITH LIFE THREATENING BLEEDING FROM TRAUMATIC INJURY. |
| 2024-03-05 | University of Rochester | $341.0K | PROVIDE SUPPORT ON STUDY DESIGN INCLUDING RANDOMIZATION SCHEME. GUIDE SAMPLE SIZE AND POWER ANALYSIS FOR THE COMPLEX BAYESIAN FACTORIAL CLUSTERED CROSS-OVER RANDOMIZATION DESIGN VIA SIMULATION. OVERSEE DATA COLLECTION… |
| 2024-03-05 | University of Rochester | $341.0K | PROVIDE SUPPORT ON STUDY DESIGN INCLUDING RANDOMIZATION SCHEME. GUIDE SAMPLE SIZE AND POWER ANALYSIS FOR THE COMPLEX BAYESIAN FACTORIAL CLUSTERED CROSS-OVER RANDOMIZATION DESIGN VIA SIMULATION. OVERSEE DATA COLLECTION… |
| 2024-03-05 | University of Rochester | $341.0K | PROVIDE SUPPORT ON STUDY DESIGN INCLUDING RANDOMIZATION SCHEME. GUIDE SAMPLE SIZE AND POWER ANALYSIS FOR THE COMPLEX BAYESIAN FACTORIAL CLUSTERED CROSS-OVER RANDOMIZATION DESIGN VIA SIMULATION. OVERSEE DATA COLLECTION… |
| 2024-03-05 | University of Rochester | $341.0K | PROVIDE SUPPORT ON STUDY DESIGN INCLUDING RANDOMIZATION SCHEME. GUIDE SAMPLE SIZE AND POWER ANALYSIS FOR THE COMPLEX BAYESIAN FACTORIAL CLUSTERED CROSS-OVER RANDOMIZATION DESIGN VIA SIMULATION. OVERSEE DATA COLLECTION… |
| 2024-11-08 | University of Alabama at Birmingham | $309.5K | FUNDS HAVE BEEN BUDGETED FOR UNIVERSITY OF ALABAMA AT BIRMINGHAM TO PLAN, ORGANIZE AND IMPLEMENT THE PROTECTIONS ASSOCIATED WITH FEDERAL REGULATIONS 21 CFR 50.24, EXCEPTION FROM INFORMED CONSENT (EFIC) REQUIREMENTS FOR… |
| 2026-07-29 | Arkansas Children'S Research Institute | $256.6K | THIS SUBAWARD IS TO SUPPORT THE MATIC-2 CLINICAL TRIAL, WHICH EXAMINES THE EFFECTIVENESS, SAFETY AND MECHANISMS BETWEEN MULTIPLE RESUSCITATION PRACTICES IN CHILDREN WITH LIFE THREATENING BLEEDING FROM TRAUMATIC INJURY |
| 2026-08-03 | University of California, San Diego | $254.0K | THIS SUBAWARD IS TO SUPPORT THE MATIC-2 CLINICAL TRIAL, WHICH EXAMINES THE EFFECTIVENESS, SAFETY AND MECHANISMS BETWEEN MULTIPLE RESUSCITATION PRACTICES IN CHILDREN WITH LIFE THREATENING BLEEDING FROM TRAUMATIC INJURY |
| 2024-09-27 | Emory University | $231.1K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-09-27 | Emory University | $231.1K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-03-01 | Baylor College of Medicine | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-04-15 | The University of Texas Health Science Center at San Antonio | $211.6K | THE MATIC-2 TRIAL IS A BAYESIAN, RANDOMIZED, MULTICENTER, ADAPTIVE PLATFORM PHASE III TRIAL. THE TRIAL WILL INCLUDE INJURED CHILDREN WITH HEMORRHAGIC SHOCK ANTICIPATED TO REQUIRE MASSIVE BLOOD TRANSFUSION, WHO WILL BE… |
| 2024-10-24 | University of California, Davis | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-10-24 | University of California, Davis | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-03-01 | Baylor College of Medicine | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-03-01 | Baylor College of Medicine | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-08-30 | Vanderbilt University Medical Center | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-08-30 | Vanderbilt University Medical Center | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-08-30 | Vanderbilt University Medical Center | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
| 2024-08-01 | University of Washington | $211.6K | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR… |
4 actions since 2023-09-15. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-08-28 | P00003 | Administrative change | $0 | CORRECT THE PERIODS OF PERFORMANCE (POP) TO REFLECT CURRENT DATES ON CONTRACT |
| 2026-05-29 | P00002 | Supplemental agreement (work within scope) | $16.50M | ADD ADDITIONAL FUNDING TO THE BASE PERIOD; UPDATE COA THRESHOLD TO $350,000; ADD BERYL VOIGT AS ALTERNATE COR; UPDATE FAR/HHSAR CLAUSES PER EXECUTIVE ORDERS AND REVOLUTIONARY FAR/HHSAR OVERHAUL (RFO); UPDATE SOW AND CONTRACT MILESTONES AND DELIVERABL |
| 2024-09-04 | P00001 | Supplemental agreement (work within scope) | $1.30M | PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH |
| 2023-09-15 | 0 | $19.81M | PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗